Differences in the percentage of patients with ACPA‐positive saliva (17%–40% in ACPA IgG‐seropositive RA) among cohorts might reflect the inclusion of only patients with moderate to high ACPA serum levels in the IntestRA study. This evidence concerns the gene PRTN3 and rheumatoid arthritis.